Oral versus intraperitoneal application of clindamycin in tunnel infections: A prospective, randomized study in CAPD patients

Peritoneal Dialysis International

Volumn 17, Issue 5, 1997, Pages 486-492

  Plum, Joerg ^a   Artik, Suzan ^a   Busch, Theo ^a   Sahin, Kurtulus ^a   Grabensee, Bernd ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Clindamycin; Route of application; Tunnel infection; Ultrasound

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; OXACILLIN;

ABSCESS; ANTIBIOTIC RESISTANCE; ARTICLE; CATHETER INFECTION; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUS; RANDOMIZED CONTROLLED TRIAL; ULTRASOUND;

EID: 0030726741     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701700512     Document Type: Article

References (29)

1. Luzar MA. Exit-site infection in continuous ambulatory peritoneal dialysis: a review. Perit Dial Int 1991; 11:333-40.
2. Holley JL, Bernardini J, Piraino B. Risk factors for tunnel infections in continuous peritoneal dialysis.Am J Kidney Dis 1991; 18:344-8.
3. Luzar MA, Brown C, Balf D, et al. Exit-site care and exit-site infection in CAPD: results of a randomized multicenter trial. Perit Dial Int 1990; 10:25-9.
4. Piraino B, Bernardini J, Sorkin M. The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1986; 8:436-40.
5. Nolph KD, Cutler SJ, Steinberg SM, Novak JW. Continuous ambulatory peritoneal dialysis in the United States: a three year study Kidney Int 1985;28:198-205.
6. Twardowski ZJ. Peritoneal catheter development. Currently used catheters advantages/disadvantages/complications, and catheter tunnel morphology in humans. ASAIO Trans 1988; 34:937-40.
7. Ludlam HA. Infectious consequences of continuous ambulatory peritoneal dialysis. J Hosp Infect 1991; 18:341-54.
8. Plum J, Sudkamp S, Grabensee B. Results of ultrasound assisted diagnosis of tunnel infections in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1994; 23:99-104.
9. Piraino B, Bernardini J, Sorkin M. A five-year study of the microbiologic results of exit-site infections and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1987; 10:281-6.
10. Jindal KK, Hirsch DJ. Excellent technique survival on home peritoneal dialysis: result of a regional program. Perit Dial Int 1994; 14:324-6.
11. Nolph KD. Technique survival in continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14:322-3.
12. Holley JL, Foulks CJ, Moss AH, Willard D. Ultrasound as a tool in the diagnosis and management of exit-site infections in patients undergoing continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1989; 14:211-16.
13. Domico J, Warman M, Jaykamur S, Sorkin MI. Is ultrasonography useful in predicting catheter loss? In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1993; 9:231-2.
14. Tzamaloukas AH, Hartshorne MF, Gibel LJ, Murata GH. Persistence of positive dialysate cultures after apparent cure of CAPD peritonitis. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1993; 9:198-201.
15. Sanyal D, Williams AJ, Johnson AP, George RC. The emergence of vancomycin resistance in renal dialysis. J Hosp Infect 1993; 24:167-73.
16. Piraino B. A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients. Am J Kidney Dis 1990; 16:89-95.
17. de Fijter CW, Verbrugh HA, Heezius HC, et al. Effect of clindamycin on the intracellular bactericidal capacity of human peritoneal macrophages. J Antimicrob Chemother 1990; 26:525-32.
18. Kazmi HR, Raffone FD, Kliger AS, Finkelstein FO. Pseudomonas exit-site infections in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1992; 2:1498-1501.
19. Passlick-Deetjen J. CAPD: klinische und klinisch experimentelle Untersuchungen zur Effektivität und Optimierung einer alternativen Behandlungsmethode der terminalen Niereninsuffizienz (Habilitationsschrift) Dusseldorf, Germany: Heinrich Heine University, 1988.
20. Oreopoulos DG. Peritoneal dialysis research for the 1990s. Perit Dial Int 1992; 12:278-80.
21. Flanigan MJ, Hochstetler LA, Langholdt D, Lim VS. Continuous ambulatory peritoneal dialysis catheter infections: diagnosis and management. Perit Dial Int 1994; 14:248-54.
22. Viglino G, Cancarini G, Catizone L, et al. Ten years of continuous ambulatory peritoneal dialysis: analysis of patient and technique survival. Perit Dial Int 1993; 13(Suppl 2):175-9.
23. Maiorca R, Cantaluppi A, Cancarini GC, et al. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1983; 2:642-4.
24. Holley JL, Bernardini J, Piraino B. Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set.Am J Kidney Dis 1994; 23:569-73.
25. Churchill DN, Taylor DW, Vas SI, et al. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multicenter randomized clinical trial comparing the Y-connector disinfectant system to standard systems. Perit Dial Int 1989; 9:159-63.
26. Schaffner AD, Zaruba K. Bedeutung der CAPD fuer die Nierenersatztherapie. Schweiz Rundsch Med Prax 1994; 83:414-25.
27. Scalamogna A, Castelnovo C, De Vecchi A, Ponticelli C. Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1991; 18:674-7.
28. Arellano E, Ramirez D, Pascual A, Martinez-Martinez L, Perea EJ. Activity of eight antibacterial agents in Staphylococcus epidermidis attached to teflon catheters. J Med Microbiol 1994; 40:43-7.
29. De Haan RM, Vanden Bosch WD, Metzler CM. Clindamycin serum concentrations after administration of clindamycin palmitate with food. J Clin Pharmacol New Drugs 1972; 12:205-11.